Victrex (LON:VCT)‘s stock had its “hold” rating reaffirmed by equities researchers at Peel Hunt in a report issued on Tuesday, ThisIsMoney.Co.Uk reports.

Several other equities analysts have also weighed in on VCT. Credit Suisse Group reaffirmed an “outperform” rating on shares of Victrex in a research note on Monday, February 10th. UBS Group reaffirmed a “sell” rating on shares of Victrex in a research note on Tuesday, February 18th. Barclays lowered Victrex to an “underweight” rating and reduced their price objective for the company from GBX 1,940 ($25.52) to GBX 1,870 ($24.60) in a research note on Friday, March 6th. Berenberg Bank reaffirmed a “hold” rating on shares of Victrex in a research note on Tuesday, January 14th. Finally, Morgan Stanley lifted their price objective on Victrex from GBX 1,800 ($23.68) to GBX 1,950 ($25.65) and gave the company an “underweight” rating in a research note on Friday, January 24th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of GBX 2,249.55 ($29.59).

Shares of LON VCT traded up GBX 166 ($2.18) during midday trading on Tuesday, hitting GBX 2,262 ($29.76). The stock had a trading volume of 1,280,154 shares, compared to its average volume of 274,177. The company has a market capitalization of $1.96 billion and a price-to-earnings ratio of 21.16. Victrex has a 1-year low of GBX 1,813.68 ($23.86) and a 1-year high of GBX 2,574 ($33.86). The company has a fifty day moving average price of GBX 2,166.94 and a 200 day moving average price of GBX 2,262.07.

In related news, insider Jakob Sigurdsson purchased 2,000 shares of Victrex stock in a transaction that occurred on Thursday, February 6th. The shares were purchased at an average cost of GBX 2,349 ($30.90) per share, with a total value of £46,980 ($61,799.53). Also, insider Richard Armitage purchased 980 shares of Victrex stock in a transaction that occurred on Thursday, March 12th. The shares were bought at an average cost of GBX 1,907 ($25.09) per share, for a total transaction of £18,688.60 ($24,583.79). Insiders have purchased a total of 2,985 shares of company stock worth $6,579,060 over the last three months.

Victrex Company Profile

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.

See Also: Cost of Goods Sold (COGS)

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.